BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 21616583)

  • 1. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
    van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
    Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
    Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time bioluminescence and tomographic imaging of gastric cancer in a novel orthotopic mouse model.
    Hu H; Liu J; Yao L; Yin J; Su N; Liu X; Cao F; Liang J; Nie Y; Wu K
    Oncol Rep; 2012 Jun; 27(6):1937-43. PubMed ID: 22407359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunocompetent murine model of metastatic mammary cancer accessible to bioluminescence imaging.
    Shibata MA; Shibata E; Morimoto J; Eid NA; Tanaka Y; Watanabe M; Otsuki Y
    Anticancer Res; 2009 Nov; 29(11):4389-95. PubMed ID: 20032383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
    Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
    Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
    Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
    BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer.
    Madero-Visbal RA; Colon JF; Hernandez IC; Limaye A; Smith J; Lee CM; Arlen PA; Herrera L; Baker CH
    Surg Oncol; 2012 Mar; 21(1):23-9. PubMed ID: 20801643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Whole-body fluorescent imaging of the growth and metastasis of GFP-expressing bladder tumors].
    Wu YD; Tan WL; Xie Y; Yu ZC; Zhao GZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):436-40. PubMed ID: 16624746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
    Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
    Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with hyaluronic acid and potentiates their malignant progression.
    Muramaki M; Miyake H; Kamidono S; Hara I
    J Urol; 2004 Jan; 171(1):426-30. PubMed ID: 14665947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
    Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
    Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
    Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.
    Comstock KE; Hall CL; Daignault S; Mandlebaum SA; Yu C; Keller ET
    In Vivo; 2009; 23(5):661-8. PubMed ID: 19779098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.